United Therapeutics Aktie
WKN: 923818 / ISIN: US91307C1027
|
05.08.2026 12:46:56
|
United Therapeutics Corp Bottom Line Climbs In Q2
(RTTNews) - United Therapeutics Corp (UTHR) announced a profit for its second quarter that Increased, from the same period last year
The company's earnings totaled $333.0 million, or $7.27 per share. This compares with $309.5 million, or $6.41 per share, last year.
The company's revenue for the period fell 1.9% to $783.3 million from $798.6 million last year.
United Therapeutics Corp earnings at a glance (GAAP) :
-Earnings: $333.0 Mln. vs. $309.5 Mln. last year. -EPS: $7.27 vs. $6.41 last year. -Revenue: $783.3 Mln vs. $798.6 Mln last year.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu United Therapeutics Corp.
Analysen zu United Therapeutics Corp.
Aktien in diesem Artikel
| United Therapeutics Corp. | 465,20 | 1,20% |
|